Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02329847
Title Pharmacokinetic and Pharmacodynamic Study to Evaluate Safety and Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | POL | ISR | ESP | AUS

Facility Status City State Zip Country Details
New York New York United States Details
Bedford Park Australia Details
Darlinghurst Australia Details
Woolloongabba Australia Details
Haifa Israel Details
Jeursalem Israel Details
Ramat Gan Israel Details
Tel Aviv Israel Details
Chorzow Poland Details
Gdansk Poland Details
Krakow Poland Details
Wroclaw Poland Details
Barcelona Spain Details
Madrid Spain Details
Salamanca Spain Details
Ankara Turkey Details
Istanbul Turkey Details
Izmir Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field